Cybin Inc N.CYBN

Alternate Symbol(s): CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

NEO:CYBN - Post by User

Cybin Inc > $Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

<< Previous

Bullboard Posts

Next >>

Comment by DogeCoinon Sep 12, 2022 9:36pm

241 Views

Post# 34958362

RE:RE:RE:$Silo Wellness' Secret Patent Mushroom Nasal Spray 🍄👃🍄

So what your saying is that this company SILO Wellness a nostril sprayy that has psilocybin in it? Jesus, this is pretty dope. Added to my MUSH watchlist. To date so far have not heard of any other comp doing this. Thanks Doc

GajjarDr wrote: https://www.silowellness.com/nasal-spray/

The Company has received feedback from potential licensees with interest in a pharmaceutical use for the nasal spray.

Silo Wellness has developed and finalized of the formulation of a psilocybin nasal spray in Jamaica, where such psychedelic compounds are legal. In addition, Silo Wellness has managed SW Holdings’ IP related to this psilocybin nasal spray via the filing of provisional and non-provisional patent applications in the United States.